Pathogenesis and management of HIV/TB co-infection in Asia (Q36868036)

16 August 2017

1 reference

title

Pathogenesis and management of HIV/TB co-infection in Asia (English)

1 reference

16 August 2017

Jerrold J Ellner

2

0 references

author name string

Anne Goldfeld

series ordinal

1

1 reference

PubMed ID

17606407

16 August 2017

language of work or name

1 reference

2 July 2007

1 reference

16 August 2017

1 reference

16 August 2017

87 Suppl 1

1 reference

16 August 2017

S26-30

1 reference

Tuberculosis in patients with human immunodeficiency virus infection

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Virological and Immunological Impact of Tuberculosis on Human Immunodeficiency Virus Type 1 Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

A Community-Based Tuberculosis Program in Cambodia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Association of an HLA-DQ allele with clinical tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

IL-10-producing T cells suppress immune responses in anergic tuberculosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Mycobacterium tuberculosis recall antigens suppress HIV-1 replication in anergic donor cells via CD8+ T cell expansion and increased IL-10 levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Ethnic-specific genetic associations with pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Clinical management of tuberculosis in the context of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.003

10.1016/J.TUBE.2007.05.003

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17606407